GSK

NEW IDEA ON HUMAN GENOME SCIENCES INC. (HGSI)

This post was published earlier on ZYX Buy Change Alert Last year  Human Genome Sciences Inc. (HGSI) successfully introduced the first new treatment for Lupus in a very long time.  GlaxoSmithKline (GSK), the big drug giant, is Human Genome’s partner. Human Genome has disclosed that it received an unsolicited $13.00 per share cash offer

Read More

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

Skip to content